Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that the Company will be presenting…
Korea’s drug regulatory body extended the use of a stem cell therapy for COVID-19 for an additional year, allowing local hospitals to use the Pharmicell…
A University of California, Irvine (UCI) researcher just received $3.8 million in the form of a five-year National Institutes of Health (NIH) grant to conduct…
A new European Union (EU)-funded project is set to provide accessible and reliable information about cell and gene-based therapies in Scotland. Known as EuroGCT, its…
Research scientists from Ohio State University are in hot pursuit of a regenerative therapy solution for ischemic stroke. By injecting a stem cell-based treatment, they…
Financing in the regenerative medicine biotech market, especially for those firms developing cell and gene therapies, absolutely explodes as last year global financing for companies…
Cambridge, Massachusetts-based gene therapy venture ElevateBio raised a staggering $525 million Series C financing to continue its pursuit of disruptive medicinal models addressing some of…
Caribou Biosciences announced the successful completion of an oversubscribed $115 million Series C financing, co-led by new premier healthcare investors Farallon Capital Management, PFM Health…
A new biotech venture called Ensoma was launched just recently, in conjunction with a sizable $70 million Series A funding thanks to the development of…
The City of Hope now seeks patients for a Phase 1 clinical trial centering on an investigational vaccine that uses a person’s own cells, a…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
